Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery
Status:
Completed
Trial end date:
2021-12-10
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the short-term effects and safety of prophylactic intra-vitreal
injection of triamcinolone-moxifloxacin combination after cataract surgery. 84 patients
underwent cataract surgery associated with intra-vitreal injection of
triamcinolone-moxifloxacin combination after surgery.